Treatment with atRA restored this change, induced weight loss, and improved insulin responsiveness, suggesting that suppression of obesity and insulin resistance by atRA is largely mediated by PPARβ/δ. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.